| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aclaris Therapeutics, Inc. (ACRS) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 14 sells. ACRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.95M | $67.66M | - | |
| Other | 510.0K | $2.47M | - | |
| COO | 336.3K | $1.63M | - | |
| CEO | 274.8K | $1.33M | - | |
| Other | 18.7K | $90.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2016 | Vivo Ventures Vii, LLC | 10% Owner | Sell | 907,828 | $23.03 | $20,908,049.25 | -11.5% | |
| Oct 26, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 3,750 | $21.94 | $82,259.50 | - | |
| Oct 26, 2016 | Ali-Jackson Kamil71 | Chief Legal Officer | Sale+OE | 3,912 | $21.83 | $85,398.96 | -4.9% | |
| Sep 28, 2016 | Ali-Jackson Kamil71 | Chief Legal Officer | Sale+OE | 1,841 | $24.66 | $45,399.06 | -2.4% | |
| Sep 16, 2016 | Ra Capital Management, LLC53 | 10% Owner | Sell | 525,550 | $24.19 | $12,713,502.44 | -4.4% | |
| Aug 26, 2016 | Ali-Jackson Kamil71 | Chief Legal Officer | Sell | 3,738 | $20.35 | $76,068.30 | -15.6% | |
| Feb 23, 2016 | Ra Capital Management, LLC53 | 10% Owner | Buy | 39,726 | $17.15 | $681,469.87 | +0.8% | |
| Jan 20, 2016 | Ra Capital Management, LLC53 | 10% Owner | Buy | 7,803 | $19.87 | $155,072.47 | +0.1% | |
| Jan 13, 2016 | Ra Capital Management, LLC53 | 10% Owner | Buy | 15,637 | $19.10 | $298,737.76 | +0.2% | |
| Oct 29, 2015 | Ra Capital Management, LLC53 | 10% Owner | Buy | 244,200 | $14.00 | $3,418,800.00 | +5.1% |